Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 2—February 2011
Research

Severe Cases of Pandemic (H1N1) 2009 in Children, Germany

Mathias AltmannComments to Author , Lena Fiebig, Jana Soyka, Rüdiger von Kries, Manuel Dehnert, and Walter Haas
Author affiliations: Author affiliations: Robert Koch Institute, Berlin, Germany (M. Altmann, L. Fiebig, J. Soyka, M. Dehnert, W. Haas); Ludwig-Maximilians-Universität, Munich, Germany (R. von Kries)

Main Article

Table 1

Underlying chronic medical conditions and vaccination status for children with severe pandemic (H1N1) 2009, Germany, 2009–2010*

Characteristic Total Nonsurvivors not in PICU Admitted to PICU
Survivors Nonsurvivors Subtotal p value OR (95% CI)
Underlying chronic medical conditions
Any 67/89 (75) 4/4 (100) 56/76 (74) 7/9 (78) 63/85 (74) 1 1.3 (0.2–13.3)
Neurodevelopmental disorders 51/89 (57) 4/4 (100) 40/75 (53) 7/10 (70) 47/85 (55) 0.501 2.0 (0.4–13.1)
Respiratory disease 31/82 (38) 2/3 (67) 25/70 (36) 4/9 (44) 29/79 (37) 0.718 1.4 (0.3–7.3)
Immunodeficiency 13/80 (16) 1/4 (25) 12/67 (18) 0/9 (0) 12/76 (16) 0.339 0.0 (0.0–2.1)
Cardiac disease
11/84 (13)
0/4 (0)
9/70 (13)
2/10 (20)
11/80 (14)
0.621
1.7 (0.2–10.6)
Vaccination status in patients >6 mo of age
Any influenza 9/56 (16) 0/4 (0) 9/48 (19) 0/4 (0) 9/52 (17) 1 0.0 (0.0–4.7)
Pandemic (H1N1) 2009 5/53 (9) 0/4 (0) 5/45 (11) 0/4 (0) 5/49 (10) 1 0.0 (0.0–9.2)

*Values are no. positive/no with available information (%) except as indicated. PICU, pediatric intensive care unit; OR, odds ratio; CI, confidence interval. ORs were calculated only among patients admitted to the PICU.

Main Article

Page created: July 13, 2011
Page updated: July 13, 2011
Page reviewed: July 13, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external